Women are detained on suspicion of false research on dengue vaccine in Ponta Porã
Two women were detained by the Military Police in Ponta Porã, Brazil, for posing as health agents conducting a fraudulent survey on a dengue vaccine.
Study done on rats reveals that a universal vaccine for treating colds, flu, and COVID-19 may work
A promising new universal vaccine candidate for colds, flu, and COVID-19 has shown encouraging results in mice, although further human trials are necessary due to differences in immune response between species.
A vaccine against Alzheimer's? Immunization against shingles reduces dementia risk by 20%
Research indicates that vaccination against shingles may lower the risk of developing dementia by 20%, providing a potential preventive strategy against cognitive decline.
RFK Jr’s pick to review Covid vaccines authored misleading research, experts say
Retsef Levi, appointed by RFK Jr to review Covid vaccine safety, has been criticized by experts for producing misleading research.
You are being sought if you meet these conditions
A comprehensive study in Finland will investigate whether the shingles vaccine reduces the incidence of dementia in individuals aged 76 and older.
A large study begins in Finland – does the vaccine work against dementia?
A significant vaccine study is commencing in Finland to determine if the shingles vaccine can reduce dementia in the elderly.
Could the shingles vaccine protect against another dangerous disease?
The article discusses research indicating a potential link between the shingles vaccine and reduced dementia risk in older adults.
The shingles vaccine as an 'elixir' against aging
New research indicates that the shingles vaccine not only prevents herpes but also appears to slow biological aging in older adults.
A new study explains how rare thrombosis occurs after Covid-19 vaccines
A new study reveals the mechanisms behind rare but serious complications following adenovirus-based Covid-19 vaccinations, known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
SUPER VACCINE: One nasal spray could replace all seasonal vaccines
Scientists are making significant progress towards a universal vaccine that could protect against colds, flu, COVID-19, and even allergies.
What We Know About Shingles Vaccine and Dementia
Research shows that the shingles vaccine may reduce the risk of dementia, but uncertainty remains about its efficacy in safeguarding memory.
Universal vaccine for cold, flu, COVID and allergies 'moves a step closer'
Scientists have developed a universal vaccine that shows promise for protection against multiple respiratory infections and allergies, based on research conducted in mice.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
In Latvia, Borrelia proteins are being studied to improve the vaccine against Lyme disease
Research in Latvia is focused on Borrelia proteins as potential components for enhancing Lyme disease vaccines.
Scientists Discover the Cause of Rare Complications from COVID-19 Vaccines
Recent research identifies potential biological causes of rare complications associated with COVID-19 vaccinations, specifically focusing on vaccine-induced immune thrombocytopenia and thrombosis (VITT).
Astra Zeneca's Thrombus Mystery Finally Solved
The international research team has identified the exact molecular mechanism behind the thromboembolic risks associated with Astra Zeneca and Johnson & Johnson vaccines during the pandemic.
Disinformation like a virus. Is it possible to create a vaccine against it?
Polish researchers indicate that existing methods to combat disinformation are not fully effective and can have side effects, prompting global scientific discussions on potential solutions.
A Spaniard leads a breakthrough that could accelerate the HIV vaccine
A Spanish scientist has made significant progress that could lead to accelerated development of an HIV vaccine, pending funding for human trials.
A vaccine to prevent colon cancer shows promising results
A preventive vaccine, Nous-209, shows promising results in initial trials with patients at a significantly higher risk of developing tumors.